Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Continued lack of news
View:
Post by westcoast1000 on Feb 22, 2023 7:17pm

Continued lack of news

The presentation at the CAR-TCR summit at 5 pm London UK time is over. There seems to be no notice or coverage of this talk on the ONCY web site. In that case, it seems the quiet period continues to be in place.

That should be encouraging for all investors, in the sense that our assumptions about news blackouts are not contradicted. Howver, an encouraging talk on the potential for pela with CAR therapy would have been appreciated also.
Comment by Noteable on Feb 22, 2023 7:48pm
ONCY remains in a quiet period of "Thoughtful Planning" - while in discussions with the FDA and potential Big Pharma acquirers.
Comment by fox7mf on Feb 22, 2023 9:09pm
Definitely. Makes you wonder if indeed the PFE 90-day exclusivity is over, and if Onc is in the process of sharing Bracelet data with any and all other BP's. One massive bidding war could be brewing, and could delay NR's for a while...to the benefit of shareholders.